Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
975871
Reference Type
Journal Article
Subtype
Abstract
Title
Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial nitric oxide bioavailability
Author(s)
Rudolph, T; Rudolph, V; Klinke, A; Lau, D; Heitzer, T; Meinertz, T; Baldus, S
Year
2008
Is Peer Reviewed?
Yes
Journal
Free Radical Biology and Medicine
ISSN:
0891-5849
EISSN:
1873-4596
Volume
45
Issue
Suppl.
Page Numbers
S135-S135
Language
English
Web of Science Id
WOS:000260867900380
URL
http://www.sciencedirect.com/science/article/pii/S089158490800631X
Exit
Relationship(s)
is part of a larger document
3452652
SFRBM's 15th Annual Meeting: Program and Abstracts
Abstract
Aim: Myeloperoxidase (MPO), a leukocyte-derived heme enzyme binds to the endothelium and depletes vascular nitric oxide (NO) bioavailability in animal models. Unfractionated heparins release vessel-bound MPO and increase endothelial NO bioavailability. Whether low molecular weight heparins also affect circulating MPO levels and NO dependent vasoreactivity however remains elusive.
Methods and Results: in a randomized, double-blind, placebo controlled trial patients with stable coronary artery disease received either 1 mg/kg enoxaparin or an equivalent volume of sodium chloride (NaCl) subcutaneously. Enoxaparin led to a significant improvement of FMD (5.51±2.92% vs. 6.55±3.16%, p=0.01) accompanied by a significant increase in plasma MPO levels (2.51 [IR: 2.04-3.62] ng/ml vs. 3.70 [IR: 2.80-5.50] ng/ml; p<0.001) whereas NaCl revealed neither a change in FMD (5.56±3.62% vs. 5.34±3.32%, p=ns) nor in plasma MPO levels (3.04 [IR: 2.22-4.67] ng/ml vs. 2.90 [IR:1.95-4.32] ng/ml; p=ns). The extent of enoxaparin-induced MPO release and the improvement in endothelial function correlated (r=0.67, P<0.001).
Conclusion: This study confirms the concept that heparins enhance vascular NO bioavailability by mobilizing vessel bound MPO. These data not only support the notion of extracoagulant, anti-inflammatory properties of heparins but reinforce the concept of MPO-dependent NO oxidation as a central mechanism for regulation of vascular tone in inflammatory vascular disease.
Conference Name
Society for Free Radical Biology and Medicine 15th Annual Meeting
Conference Location
Indianapolis, IN
Conference Dates
November 19-23, 2008
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity